We chose triple negative breast tumor resection specimens as the test substrate and selected three panels (Tact, PD-L1 and APC) directed against human antigens that identify and localize cell populations that are important to the pathogenesis and treatment of neoplastic diseases. The gene discussed is CD274; the disease is neoplasm.